SARA LABORDE DEMARS: Open Payments
NPI 1417487638 · MARKSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 17 payments from 8 companies in 2025. Trend: 2023 $390 · 2024 $447 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $233 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $52 |
| Abbott Laboratories | 2 | $39 |
| Tris Pharma Inc | 2 | $30 |
| Lilly USA, LLC | 1 | $24 |
| Insulet Corporation | 1 | $24 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Auvelity, REXULTI, VRAYLAR, FREESTYLE LIBRE 3, Dyanavel XR, JARDIANCE, Omnipod, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
